Most cited papers from Imelda Hospital

Imelda Hospital

What are the most cited papers from Imelda Hospital?

The most cited paper from Imelda Hospital is "Cetuximab and Chemotherapy as Initial Treatment for Metastatic Colorectal Cancer" (Eric Van Cutsem, Claus-Henning Köhne, Erika Hitre et al., 2009), with 3,899 citations. Next come "Infliximab, Azathioprine, or Combination Therapy for Crohn's Disease" (3,137) and "Classification of primary and incisional abdominal wall hernias" (1,423).

Published TypeFieldAccessAuthorsCitations

Showing 50 of 60 papers. Every paper with more than 179 citations is listed.

Most cited papers, sortable by citations and release date
#	Paper
1	Cetuximab and Chemotherapy as Initial Treatment for Metastatic Colorectal Cancer Eric Van Cutsem, Claus-Henning Köhne, Erika Hitre et al. · New England Journal of Medicine Open access	Apr 2009	3,899
2	Infliximab, Azathioprine, or Combination Therapy for Crohn's Disease Jean‐Frédéric Colombel, William J. Sandborn, Walter Reinisch et al. · New England Journal of Medicine Open access	14 Apr 2010	3,137
3	Classification of primary and incisional abdominal wall hernias Filip E. Muysoms et al. · Hernia Open access	2 Jun 2009	1,423
4	ECCO Guidelines on Therapeutics in Crohn's Disease: Medical Treatment Joana Torres et al. · Journal of Crohn s and Colitis Open access	2 Nov 2019	1,378
5	Adalimumab Induces and Maintains Clinical Remission in Patients With Moderate-to-Severe Ulcerative Colitis William J. Sandborn, Gert Van Assche, Walter Reinisch et al. · Gastroenterology	5 Nov 2011	1,274
6	Early combined immunosuppression or conventional management in patients with newly diagnosed Crohn's disease: an open randomised trial Geert D’Haens et al. · The Lancet	Feb 2008	1,243
7	ECCO Guidelines on Therapeutics in Crohn’s Disease: Surgical Treatment Michel Adamina et al. · Journal of Crohn s and Colitis Open access	15 Nov 2019	1,128
8	Use of the Instantaneous Wave-free Ratio or Fractional Flow Reserve in PCI Justin E. Davies et al. · New England Journal of Medicine Open access	18 Mar 2017	982
9	Adalimumab Induction Therapy for Crohn Disease Previously Treated with Infliximab William J. Sandborn, Paul J. Rutgeerts, Robert Enns et al. · Annals of Internal Medicine	19 Jun 2007	963
10	Effect of tight control management on Crohn's disease (CALM): a multicentre, randomised, controlled phase 3 trial Jean‐Frédéric Colombel et al. · The Lancet	30 Oct 2017	931
11	Mucosal Healing Predicts Sustained Clinical Remission in Patients With Early-Stage Crohn's Disease Filip Baert, Liesbeth Moortgat, Gert Van Assche et al. · Gastroenterology Open access	9 Oct 2009	837
12	Fecal calprotectin is a surrogate marker for endoscopic lesions in inflammatory bowel disease Geert D’Haens, Marc Ferrante, Severine A.R.A. Vermeire et al. · Inflammatory Bowel Diseases Open access	16 Feb 2012	823
13	European evidence based consensus for endoscopy in inflammatory bowel disease Vito Annese, Marco Daperno, Matthew D. Rutter et al. · Journal of Crohn s and Colitis Open access	Nov 2013	819
14	Ticagrelor plus aspirin for 1 month, followed by ticagrelor monotherapy for 23 months vs aspirin plus clopidogrel or ticagrelor for 12 months, followed by aspirin monotherapy for 12 months after implantation of a drug-eluting stent: a multicentre, open-label, randomised superiority trial Pascal Vranckx et al. · The Lancet Open access203 authors	27 Aug 2018	797
15	YERSINIA ENTEROCOLITICA INFECTIONS AND PORK: THE MISSING LINK Robert V. Tauxe, G. Wauters, Valère J. Goossens et al. · The Lancet	May 1987	651
16	A Genotype-Guided Strategy for Oral P2Y 12 Inhibitors in Primary PCI Daniel M.F. Claassens, Gerrit J.A. Vos, Thomas O. Bergmeijer et al. · New England Journal of Medicine Open access	3 Sep 2019	649
17	Development of the Crohnʼs disease digestive damage score, the Lémann score Benjamin Pariente et al. · Inflammatory Bowel Diseases Open access	28 Nov 2010	590
18	Adalimumab Induces and Maintains Mucosal Healing in Patients With Crohn's Disease: Data From the EXTEND Trial Paul J. Rutgeerts, Gert Van Assche, William J. Sandborn et al. · Gastroenterology	8 Feb 2012	587
19	Therapeutic endoscopic ultrasound: European Society of Gastrointestinal Endoscopy (ESGE) Guideline Van der Merwe, Roy L.J. van Wanrooij, Michiel J. Bronswijk et al. · Endoscopy Open access	22 Dec 2021	505
20	Withdrawal of Immunosuppression in Crohn's Disease Treated With Scheduled Infliximab Maintenance: A Randomized Trial Gert Van Assche, Charlotte Magdelaine–Beuzelin, Geert D’Haens et al. · Gastroenterology Open access	10 Mar 2008	499
21	Risankizumab as induction therapy for Crohn's disease: results from the phase 3 ADVANCE and MOTIVATE induction trials Geert D’Haens et al. · The Lancet Open access	May 2022	424
22	Aspirin with or without Clopidogrel after Transcatheter Aortic-Valve Implantation Jorn Brouwer et al. · New England Journal of Medicine Open access	30 Aug 2020	423
23	Systematic review and meta-analysis of the effect of the World Health Organization surgical safety checklist on postoperative complications Jochen Bergs, Johan Hellings, Irina Cleemput et al. · British journal of surgery Review	27 Jan 2014	392
24	Drug-Eluting Balloon Versus Standard Balloon Angioplasty for Infrapopliteal Arterial Revascularization in Critical Limb Ischemia Thomas Zeller, Iris Baumgärtner, Dierk Scheinert et al. · Journal of the American College of Cardiology Open access	Oct 2014	388
25	Effects of Adalimumab Therapy on Incidence of Hospitalization and Surgery in Crohn's Disease: Results From the CHARM Study Brian G. Feagan, Remo Panaccione, William J. Sandborn et al. · Gastroenterology Open access	4 Aug 2008	374
26	Adalimumab for the treatment of fistulas in patients with Crohn’s disease J F Colombel, David Asa Schwartz, William J. Sandborn et al. · Gut Open access	6 Feb 2009	363
27	Anticoagulation with or without Clopidogrel after Transcatheter Aortic-Valve Implantation Vincent Johan Nijenhuis et al. · New England Journal of Medicine Open access	29 Mar 2020	350
28	A Novel Intravenous Iron Formulation for Treatment of Anemia in Inflammatory Bowel Disease: The Ferric Carboxymaltose (FERINJECT ® ) Randomized Controlled Trial Stefanie Kulnigg, Simeon Stoinov, Vladimir Simanenkov et al. · The American Journal of Gastroenterology	26 Mar 2008	349
29	Risankizumab as maintenance therapy for moderately to severely active Crohn's disease: results from the multicentre, randomised, double-blind, placebo-controlled, withdrawal phase 3 FORTIFY maintenance trial Marc Ferrante et al. · The Lancet Open access	May 2022	341
30	Development of the Lémann Index to Assess Digestive Tract Damage in Patients With Crohn's Disease Benjamin Pariente et al. · Gastroenterology Open access	21 Sep 2014	322
31	Does Free Cell Area Influence the Outcome in Carotid Artery Stenting? Marc Bosiers, Gianmarco de Donato, Koen R. Deloose et al. · European Journal of Vascular and Endovascular Surgery Open access	10 Nov 2006	321
32	Increasing Infliximab Dose Based on Symptoms, Biomarkers, and Serum Drug Concentrations Does Not Increase Clinical, Endoscopic, and Corticosteroid-Free Remission in Patients With Active Luminal Crohn’s Disease Geert D’Haens et al. · Gastroenterology Open access	6 Jan 2018	303
33	Therapy of Metronidazole With Azathioprine to Prevent Postoperative Recurrence of Crohn's Disease: A Controlled Randomized Trial Geert D’Haens, Severine A.R.A. Vermeire, Gert Van Assche et al. · Gastroenterology Open access	17 Jul 2008	299
34	Budesonide in collagenous colitis: A double-blind placebo-controlled trial with histologic follow-up Filip Baert, Alain Schmit, Geert D’Haens et al. · Gastroenterology Open access	2002	276
35	Preliminary Results After Application of Absorbable Metal Stents in Patients With Critical Limb Ischemia Patrick Peeters, Marc Bosiers, J Verbist et al. · Journal of Endovascular Therapy	31 Jan 2005	276
36	Randomized comparison of everolimus-eluting versus bare-metal stents in patients with critical limb ischemia and infrapopliteal arterial occlusive disease Marc Bosiers, Dierk Scheinert, Patrick Peeters et al. · Journal of Vascular Surgery Open access	14 Dec 2011	275
37	Sarcopenia, osteoporosis and frailty Evelien Gielen, Jolan Dupont, Marian Dejaeger et al. · Metabolism	20 Jun 2023	261
38	The effectiveness of hysteroscopy in improving pregnancy rates in subfertile women without other gynaecological symptoms: a systematic review J.J.A. Bosteels, Steven Weyers, Patrick Puttemans et al. · Human Reproduction Update ReviewOpen access	10 Sep 2009	257
39	Effect of a Telemonitoring-Facilitated Collaboration Between General Practitioner and Heart Failure Clinic on Mortality and Rehospitalization Rates in Severe Heart Failure: The TEMA-HF 1 (Telemonitoring in the Management of Heart Failure) Study Paul Dendale, Gilles W. De Keulenaer, Pierre Troisfontaines et al. · European Journal of Heart Failure Open access	Nov 2011	251
40	Deep Remission at 1 Year Prevents Progression of Early Crohn’s Disease Ryan C. Ungaro et al. · Gastroenterology Open access	26 Mar 2020	244
41	Hysterectomy by transvaginal natural orifice transluminal endoscopic surgery versus laparoscopy as a day‐care procedure: a randomised controlled trial JF Baekelandt, PA De Mulder, Ilse Le Roy et al. · BJOG An International Journal of Obstetrics & Gynaecology Open access	16 Oct 2018	242
42	Azathioprine and 6-Mercaptopurine for the Prevention of Postoperative Recurrence in Crohn's Disease: A Meta-Analysis Laurent Peyrin‐Biroulet, Pierre Deltenre, Sandro Ardizzone et al. · The American Journal of Gastroenterology Review	30 Jun 2009	238
43	Sexual Dysfunction in Women With Type 1 Diabetes Paul Enzlin, Chantal Mathieu, Annick Van den Bruel et al. · Diabetes Care	Apr 2002	237
44	Binimetinib, Encorafenib, and Cetuximab Triplet Therapy for Patients With BRAF V600E–Mutant Metastatic Colorectal Cancer: Safety Lead-In Results From the Phase III BEACON Colorectal Cancer Study Eric Van Cutsem, Sanne C.F.A. Huijberts, Axel F. Grothey et al. · Journal of Clinical Oncology Open access	20 Mar 2019	234
45	Nitinol Stent Implantation in Long Superficial Femoral Artery Lesions: 12-Month Results of the DURABILITY I Study Marc Bosiers, Giovanni Battista Torsello, Hans‐Martin Gissler et al. · Journal of Endovascular Therapy	Jun 2009	212
46	Review article: defining remission in ulcerative colitis Simon P.L. Travis, Peter Higgins, Timothy R. Orchard et al. · Alimentary Pharmacology & Therapeutics	25 May 2011	211
47	Effects of Orthogeriatric Care Models on Outcomes of Hip Fracture Patients: A Systematic Review and Meta-Analysis Annelore Van Heghe, Gilles Mordant, Jolan Dupont et al. · Calcified Tissue International ReviewOpen access	30 Sep 2021	210
48	Consecutive Fecal Calprotectin Measurements to Predict Relapse in Patients with Ulcerative Colitis Receiving Infliximab Maintenance Therapy Martine De Vos et al. · Inflammatory Bowel Diseases	24 Jul 2013	207
49	Frailty and Mortality in Hospitalized Older Adults With COVID-19: Retrospective Observational Study Robert De Smet, Bea Mellaerts, Hannelore Vandewinckele et al. · Journal of the American Medical Directors Association Open access	8 Jun 2020	206
50	ECCO Position Paper: Harmonization of the Approach to Ulcerative Colitis Histopathology Fernando Magro, Glen A. Doherty, Laurent Peyrin‐Biroulet et al. · Journal of Crohn s and Colitis Open access	Jun 2020	202

Citations are OpenAlex's own counts, from its 2026-09-23 snapshot, so the ranking can differ from Google Scholar or Web of Science. A paper is listed for an institution when any of its authors gave it as an affiliation; retracted papers and papers whose citation count cannot be traced to citing works are left out, and a preprint and the article it became are shown once. Release dates are OpenAlex's: where a source gave only a month or a year, that is what is shown. How the lists are chosen.